Form 4 for RYTM RHYTHM PHARMACEUTICALS, INC.
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001104659-23-022800 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | 2023-02-14 | RYTM | Mazabraud Yann | EVP, Head of International | S - Sale | $27.03 | -1,177 | 3,827 | -24% | -$31.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | S | D | 1,177 | $27.03 | 3,827 | D | — | — |